Thieme E-Books & E-Journals -
Back
Pharmacopsychiatry 2021; 54(05): 225-231
DOI: 10.1055/a-1385-0263
Original Paper

Impacts on Quality of Life with Escitalopram Monotherapy and Aripiprazole Augmentation in Patients with Major Depressive Disorder: A CAN-BIND Report

Emma Morton
1   Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
,
Venkat Bhat
2   Department of Psychiatry, University of Toronto, Toronto, ON, Canada
,
Peter Giacobbe
2   Department of Psychiatry, University of Toronto, Toronto, ON, Canada
,
Wendy Lou
3   Dalla Lane School of Public Health, University of Toronto, ON, Canada
,
Erin E. Michalak
1   Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
,
Trisha Chakrabarty
1   Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
,
Benicio N. Frey
4   Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON, Canada
,
Roumen V. Milev
5   Departments of Psychiatry and Psychology, Queen’s University, Kingston, ON, Canada
,
Daniel J. Müller
2   Department of Psychiatry, University of Toronto, Toronto, ON, Canada
,
Sagar V. Parikh
6   Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA
,
Susan Rotzinger
2   Department of Psychiatry, University of Toronto, Toronto, ON, Canada
,
Sidney H. Kennedy
2   Department of Psychiatry, University of Toronto, Toronto, ON, Canada
,
Raymond W. Lam
1   Department of Psychiatry, University of British Columbia, Vancouver, BC, Canada
,
on behalf of the CAN-BIND Investigator Team › Author Affiliations